ROKIT HEALTHCARE Past Earnings Performance

Past criteria checks 0/6

ROKIT HEALTHCARE has been growing earnings at an average annual rate of 42.7%, while the Pharmaceuticals industry saw earnings growing at 4.4% annually. Revenues have been growing at an average rate of 19.8% per year.

Key information

42.72%

Earnings growth rate

43.42%

EPS growth rate

Pharmaceuticals Industry Growth	11.32%
Revenue growth rate	19.83%
Return on equity	n/a
Net Margin	-58.31%
Last Earnings Update	31 Dec 2024

Recent past performance updates

No updates

Recent updates

No updates

Revenue & Expenses Breakdown

How ROKIT HEALTHCARE makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A376900 Revenue, expenses and earnings (KRW Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
31 Dec 24	13,111	-7,646	9,711	1,571
30 Sep 24	13,147	12,143	8,451	1,455
30 Jun 24	13,942	12,090	9,058	1,548
31 Mar 24	13,273	18,632	8,161	1,647
31 Dec 23	12,418	16,600	8,822	1,772
30 Sep 23	11,556	47,073	9,327	1,819
30 Jun 23	10,489	45,522	9,973	1,981
31 Mar 23	9,960	3,300	12,539	2,353
31 Dec 22	9,151	1,875	12,911	2,979
30 Sep 22	7,259	-84,255	13,332	3,414
30 Jun 22	6,583	-85,041	13,419	3,817
31 Mar 22	6,760	-55,417	13,973	4,046
31 Dec 21	6,741	-56,247	13,989	3,825
30 Sep 21	6,746	-26,170	15,335	3,638
30 Jun 21	6,106	-32,688	15,930	3,584
31 Mar 21	4,556	-33,145	13,815	3,179
31 Dec 20	3,990	-35,228	12,686	2,902
31 Dec 19	10,192	-5,497	8,310	1,279
31 Dec 18	2,298	-10,699	2,557	1,300
31 Dec 17	2,021	-3,201	1,428	973

Quality Earnings: A376900 is currently unprofitable.

Growing Profit Margin: A376900 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A376900 is unprofitable, but has reduced losses over the past 5 years at a rate of 42.7% per year.

Accelerating Growth: Unable to compare A376900's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A376900 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (0.06%).

Return on Equity

High ROE: A376900's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/15 03:48
End of Day Share Price	2025/05/15 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ROKIT HEALTHCARE Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.